Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma

Last updated: August 27, 2024
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Squamous Cell Carcinoma

Head And Neck Cancer

Carcinoma

Treatment

Paclitaxel (neoadjuvant)

Anti-PD-1 Drugs

Carboplatin( neoadjuvant)

Clinical Study ID

NCT06575322
SYSKY-2024-646-01
  • Ages 18-80
  • All Genders

Study Summary

The goal of this observational study is to learn about the Effects of neoadjuvant therapy with carboplatin, paclitaxel combined with anti-PD-1 drugs on pain, anxiety and depression in patients with operable head and neck squamous cell carcinoma: a prospective cohort study

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 1: Clinical diagnosis of head and neck squamous cell carcinoma (stage I-IVA),without prior treatment, and planning to undergo either surgical treatment alone orsurgical treatment combined with chemotherapy and immunotherapy.

2: Ability to speak Chinese and possess basic reading and writing skills.

Exclusion

Exclusion Criteria:

  • 1: Presence of mental illnesses such as dementia or delirium.

2: Active use of narcotic drugs, including consuming alcohol more than 4 times perday or more than 4 times per week.

3: Patients who alter their treatment plan during the course of treatment.

4: Current or prior use of antidepressants.

Study Design

Total Participants: 302
Treatment Group(s): 4
Primary Treatment: Paclitaxel (neoadjuvant)
Phase:
Study Start date:
September 01, 2024
Estimated Completion Date:
March 01, 2027

Connect with a study center

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Guanzhou, Guangdong 510000
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.